Leveraging WeChat Social-Media and Messaging Platform to Increase Physical Activity in Chinese Glaucoma Patients
NCT ID: NCT03567226
Last Updated: 2019-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2018-06-25
2018-11-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Visual Aids on Glaucoma Surgical Patients
NCT06478095
Exercise Intervention in Primary Open-angle Glaucoma
NCT05704777
Improving African American Glaucoma Patient Involvement in Visits and Outcomes
NCT03657147
Development of the Glaucoma Visual Functioning Questionnaire-40 and Its Psychometric Properties
NCT04722861
Glaucoma Exercise as Medicine Study (GEMS).
NCT05581498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
The intervention group will be enrolled into a WeChat Group to receive reminders to exercise and health education materials.
WeChat Group
Consenting participants will be randomized to either the intervention or the control arm after successfully wearing an accelerometer for one week. The WeChat Group will be a community forum to share information, encourage each other, and receive communications from the study team. In addition, the study team will disseminate the following information through the group:
1. Daily/Weekly Reminders to exercise
2. Health education materials regarding glaucoma and general health and exercise
3. Motivational content
4. Surveys to gauge what information participants found most interesting and useful to help them exercise
Control Group
Controls will receive a handout telling them to increase walking and that walking may be helpful for the eye at the return visit.
Counselling
Study participants in the control group will receive a handout telling them to increase walking and will be counseled that walking may be helpful for the eye at the return visit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WeChat Group
Consenting participants will be randomized to either the intervention or the control arm after successfully wearing an accelerometer for one week. The WeChat Group will be a community forum to share information, encourage each other, and receive communications from the study team. In addition, the study team will disseminate the following information through the group:
1. Daily/Weekly Reminders to exercise
2. Health education materials regarding glaucoma and general health and exercise
3. Motivational content
4. Surveys to gauge what information participants found most interesting and useful to help them exercise
Counselling
Study participants in the control group will receive a handout telling them to increase walking and will be counseled that walking may be helpful for the eye at the return visit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 40 years and above
* Ability to sign informed consent
* Ability to use WeChat
Exclusion Criteria
* Patients who self-report walking 12,000 steps or more per day
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wenzhou Medical University
OTHER
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Friedman, MD, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Yuanbo Liang, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Clinical & Epidemiological Eye Research Centre, The affiliated eye hospital of Wenzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The affiliated eye hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00172315
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.